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set to examine the differences in hospital management
and short-term and long-term mortality of patient receiv-
ing furosemide bolus or infusion treatment for ADHF.
This is a retrospective cohort study of 207 patients
admitted to KKUH with ADHF. Clinical data, labs, in-
hospital outcomes and long-term mortality data were col-
lected through review of medical records and HEARTS
registry database. We stratified our cohort into two
groups; furosemide infusion and bolus groups.The Mean
age was 61.5 ± 13.87 years, and 66.2% were males.
Approximately 42% had left ventricular ejection fraction
LVEF <40%. Use of intravenous infusions furosemide
and boluses during admission was 42.86% and 57.14%,
respectively. Compared to patient received bolus ther-
apy, patients on infusion therapy had more renal impair-
ment at presentation (26.4% vs. 12.5%, p = 0.033) and
anemia (18.1% vs. 4.25, P = 0.006). They had less diabetes
(30.6% vs. 38.5%, p = 0.006) and prior MI (18.1% vs. 32.3%,
p = 0.006). Infusion group received higher total daily
diuretic dose (p < 0.001), more Metolazone (19.4% vs.
3.1%, p = 0.002) and mechanical ventilation (11.1% vs.
3.1, p = 0.038). There was no difference in total urine out-
put and renal outcomes between the two groups. The
infusion group had longer hospital stay (15.40 ± 12.14
vs. 10.26 ± 6.74 days, p < 0.001). The long-term mortality
up to 3 years was significantly higher among patient
who received infusion therapy (27.78% vs. 9.38%,
p = 0.002). ADHF patients who received furosemide infu-
sion needed higher diuretic dose, had significantly longer
hospital stay and higher long-term mortality.
http://dx.doi:10.1016/j.jsha.2016.04.032
32. Ultra-fast, low high-pitch (flash) versus pro-
spectively gated coronary computed tomography
angiographyq
O. smettei, S. Sayed, A. Al Habeed, F. Al Harby,
R. Abazid
PSCCQ, burydah, Saudi Arabia
Coronary computed tomography angiography (CTA)
is increasingly being used for evaluation of coronary
artery disease (CAD), but Radiation exposure still a major
limitation of its use.We hypothesized that the high pitch
spiral (FLASH) is superior to prospective (step and shoot
(SAS)) ECG gating scan protocol, and associated with a
low radiation exposure. The purpose of our study is to
compare image quality and radiation exposure in a two
group of patients undergoing CTA using a 256-slice dual
source helical CT scanner with FLASH or SAS protocols.
We randomized 162 patients referred for coronary CTA
for either FLASH or SAS scanning protocols, subjective
Image quality was graded based on a 4-point grading
system (1: non diagnostic, 2: adequate, 3: good, 4: excel-
lent). While Objective image quality was assessed using
image signal, noise, and signal-to-noise ratio (SNR).
The effective radiation dose was also estimated.The clinical
and demographic characteristics of the patients in both
groups were similar. We found that subjective image qual-
ity obtained with FLASH was superior to SAS (3.35  0.6
vs. 2.82  0.61 mSv; p < 0.001), image noise was not statisti-
cally different (25.0  6.13 24.0 6.8, p = 0.10), while the
signal and SNR was significantly higher with FLASHCom-
pared to SAS (469  116 vs. 397  106. P = < 0.001) and
(21.9  8.7 vs. 16.6  7.7 mSv; p < 0.001) respectively. Radia-
tion exposure was 62% lower in FLASH compared to SAS
protocol, (1.9  0.4 mSv vs. 5.12  1.8 mSv; p < 0.001). Use
of 256-slice CTA performed with FLASH protocol has bet-
ter objective and subjective image quality, lower radiation
exposure when compared with the use of prospective ECG
gating.
http://dx.doi:10.1016/j.jsha.2016.04.033
33. Moderate ischemic mitral regurgitation:
Revascularization alone versus revascularization
and mitral valve repair
H. bakr
Madina Cardiac Centre, Madinaha, Saudi Arabia
Ischemic mitral regurgitation (IMR) can be defined as
mitral valve (MV) insufficiency caused by coronary artery
disease and excluding other causes of mitral pathology as
rheumatic,myxomatous, infectious, congenital, or connec-
tive tissue diseases ,it usually occurs with right or circum-
flex coronary infarction that involves the posterior
ventricular wall, posterior papillary muscle, and adjacent
mitral annulus (1). The management of IMR represents a
therapeutic challenge. Although most patients are treated
medically, many patients are referred for surgery. Some
authors claimed that revascularization alone is sufficient
for managing those patients (3), whereas others have
recommended revascularization combined with mitral
valve repair (2). There is a general agreement that patients
with mild mitral regurge (1+) are treated with coronary
artery bypass surgery (CABG) alone and thosewith severe
(3+ or 4+) IMR should undergo mitral valve surgery at the
time of CABG surgery. However, the importance of mod-
erate IMR (2+) is still controversial..
A prospective controlled randomized study includes
(60 patients with IHD undergoing CABG with ischemic
mitral regurge aged from 40 to 65 years of both sexes).
They will be divided into two groups of patients: Group
I: 30 patients with IHD and moderate IMR undergoing
on pump CABG for revascularization only. Group II: A
30 patients with IHD and moderate IMR undergoing on
pump CABG for revascularization and mitral valve
repair.
Study made from January, 2014 to August, 2015, at
Medina Cardiac Centre that the presence of moderate
(2+) ischaemic mitral regurgitation in ischaemic heart
disease patients undergoing revascularization alone
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does not add any additional burden to the operative risk
nor does it affect the immediate and early outcome of
these patients. That revascularization alone can amelio-
rate moderate ischaemic mitral regurgitation in most
patients postoperatively. This improvement is translated
into an improvement in the functional class and the
quality of life postoperatively there is no statistical dif-
ference between two groups.Also a procedure to
address the mitral valve in moderate IMR should be
considered in patients with a worse preoperative left
ventricular profile.
http://dx.doi:10.1016/j.jsha.2016.04.034
34.Cardiovascular complications among individuals
with amphetamine-positive urine drug screening in
King Abdulaziz Medical City, Riyadh
T. Almugren a, S. Alrawkan b
aKSAU-HS, Riyadh, Saudi Arabia; bKFNGH, Riyadh,
Saudi Arabia
Background: Amphetamine is the most commonly used
illicit drug in Saudi Arabia (SA). Frequency and outcome
of Amphetamine-related cardiovascular (CV) complica-
tions in Saudi Arabia have not been previously studied.
Aim: To determine the epidemiological aspects and
clinical outcomes of the cardiovascular complications
among individuals with Amphetamine-Positive Urine
Drug Screening (APUDS) who were admitted to a large
tertiary care facility in Riyadh, SA.
Methods: Retrospective, case-series review of consecu-
tive individuals found to have APUDS and admitted to
King Abdul-Aziz Medical City (KAMC) in Riyadh, SA
between January 2006 through December 2013 inclusive.
Cases with APUDS and concurrent positive cardiac bio-
markers and/or admission to a cardiology unit were
enrolled in the review. Demographic and clinical data
were collected from electronic patient records. All data
variables were managed and analyzed by Microsoft-
Excel and IBM-SPSS software, version 20.
Results: A total of 7450 UDS were performed during the
study period, out of which 720 (9.6%) were positive for
Amphetamine. Forty-two admissions with APUDS were
documented to have CV complications. All cases were
males with a mean age of 41  10 years and predomi-
nantly Saudis. Acute Coronary Syndrome (ACS) was
the most frequent clinical presentation (n = 31, 73.8%),
predominantly of ST Elevation Myocardial Infarction
(STEMI) type. Other less frequent complications include
myoperecarditis and cardiomyopathy. Coronary proce-
dures were performed in 30 cases. Average hospital stay
was 7 days and in-hospital mortality was 7.2%.
Conclusions and Recommendations: ACS is the most fre-
quent CV complication in the Amphetamine users.
Amphetamine-related CV complications tend to occur
at younger age and carry high risk of in-hospital mortal-
ity. UDS should be performed routinely for all indivi-
duals presenting with acute coronary syndrome or
heart failure at young age. Confirmatory test should be
routine available as a standard of care.
http://dx.doi:10.1016/j.jsha.2016.04.035
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35. With full antiplatelet and anticoagulant cover-
age: Still aortic root and left main coronary artery
thrombosis can occur early post left ventricular
assist device implantation
M. alassal
KFMC, Benha, Egypt
We describe a case of 39 years old male underwent
continuous flow LVAD implantation (HeartWare) HVAD
as destination therapy (DT) for severe left ventricular
dysfunction ,moderate right ventricular dysfunction and
severe pulmonary hypertension , presented 3rd day
post-operatively with polymorphic ventricular tachycar-
dia (VT storm) alternating with VF then aborted to brady-
cardia with complete heart block .Coronary angiography
revealed big LM coronary artery thrombus extended dis-
tally to mid LCX and mid LAD arteries and pedunculat-
ing into the aortic root proximally inspite of full coverage
with antiplatelet and anticoagulant therapy. To our
knowledge this is the 1st case documented with this early
presentation post (HeartWare) HVAD device implanta-
tion as destination therapy (DT).We describe a case of
39 years old male underwent continuous flow LVAD
implantation (HeartWare) HVAD as destination therapy
(DT) for severe left ventricular dysfunction, moderate
right ventricular dysfunction and severe pulmonary
hypertension , presented 3rd day post-operatively with
polymorphic ventricular tachycardia (VT storm) alternat-
ing with VF then aborted to bradycardia with complete
heart block . Coronary angiography revealed big LM cor-
onary artery thrombus extended distally to mid LCX and
mid LAD arteries and pedunculating into the aortic root
proximally inspite of full coverage with antiplatelet and
anticoagulant therapy. To our knowledge this is the 1st
case documented with this early presentation post
(HeartWare) HVAD device implantation as destination
therapy (DT). In the modern era, the use of surgically
implanted left ventricular assist devices (LVADs) as a
bridge therapy to either recovery or cardiac transplanta-
tion has given a hope at the end of the HF tunnel. More
recently, the use of LVADs as ‘destination therapy (DT)’
has further illuminated a future for patients with end-
stage HF. To our knowledge this is the 1st case documen-
ted with this early presentation post (HeartWare)HVAD
device implantation as destination therapy (DT).
http://dx.doi:10.1016/j.jsha.2016.04.036
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